BTC, formerly known as RALOXIFENE CORE, is a selective and orally active estrogen receptor modulator (SERM) with a pIC50 of 0.46. It acts by inducing regression of tamoxifen-resistant, hormone independent xenograft tumors. It has the potential for treating Tamoxifen-resistant, hormone independent xenograft tumors.

纯度：≥98%

CAS：63676-22-2